Preferred Label : meningeal hemorrhage;

Details


Main resources

You can consult :


https://campus.neurochirurgie.fr/article1789.html
2024
France
educational course
subarachnoid hemorrhage
Cellular Morphology
Entity
Hemorrhage
meningeal hemorrhage
Meningeal
Clinical Item

---
https://www.cen-neurologie.fr/second-cycle/hemorragie-meningee-non-traumatique
France
educational course
Other Preoperative IV Medications were not Administered
EGFR Amplification Analysis Was Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Physician Diagnosed Diabetes Absent
Preoperative IV Antacids were not Administered
ERBB2 Mutation Analysis Was Not Performed
IDH Family Mutation Analysis Was Not Performed
ATRX Gene Mutation Negative
Unemployed
Neither Case or Control Status
Chemotherapy Not Received
NON Mouse
No History of Neonatal Complication
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Hypertension Absent
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
ROS1 Rearrangement Analysis Was Not Performed
No Known History of Alcohol Use
Tumor Reoccurrence Absent After Initial Treatment
History of Colorectal Cancer Negative
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
New Disease is not Multifocal
Preoperative IV Opiates were not Administered
Additional Surgery for New Tumor Event Absent
traumatic haemorrhage
EGFR Mutation Analysis Was Not Performed
ALK Rearrangement Analysis Was Not Performed
Neither
No Known History of Illicit Drug Use
Intervention Not Given for Kawasaki Disease
SDH Complex Mutation Analysis Was Not Performed
Caffeine Not Routinely Consumed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Traumatic Hemorrhage
Lymph Node Dissection Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Not Lost to Follow-Up
1p/19q Deletion Analysis Was Not Performed
Paraneoplastic Syndrome is Not Present
BRAF Rearrangement Analysis Was Not Performed
PTEN Gene Mutation Negative
KRAS Mutation Analysis Was Not Performed
Cancer History Absent
Chief Complaint Not Caused by Trauma
KIT Mutation Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Has No Sibling
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
History of Medical Treatment Absent
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Medication Not Taken
meningeal hemorrhage
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Preoperative IV Sedation was Not Administered
Adjuvant I-131 Therapy Negative
Documentation Absent
IDH Family Wildtype
Norway
Another Form of Birth Control was not Used
No History of Rheumatic Fever
Adjuvant Post-operative Radiation Therapy Was Not Administered
subarachnoid hemorrhage, traumatic
Nitric Oxide Measurement
Nitric Oxide
New Tumor Event After Initial Treatment Absent
Patient was not Postmenopausal with no Prior Oophorectomy
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
No Response to Intervention for Kawasaki Disease
Additional Surgery for New Metastatic Tumor Event Was Not Performed
No History of Myopathy
Minor Criteria for Rheumatic Heart Disease Not Present
Negation
Additional Immunohistochemistry Was Not Performed
Any Metastatic Diagnosis Absent
Meningeal
NRAS Mutation Analysis Was Not Performed
Regional Anesthesia was not Administered
EGFR Gene Amplification Negative
Local Anesthesia Agents were not Administered
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Chief Complaint was Not Witnessed
Routine Cytogenetics Were not Completed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
10q23/PTEN Locus Deletion Analysis Was Not Performed
Radiation Therapy Not Received
No History of Congenital Heart Disease
First Degree Family History Thyroid Cancer Negative
Additional Molecular Studies Were Not Performed
ATRX Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
TP53 Mutation Analysis Was Not Performed
No History of Non-Cardiac Surgery
Preoperative IV Antiemetics were not Administered
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Kawasaki Disease
Family History of Stomach Cancer Absent
Adjuvant Post-operative Chemotherapy Was Not Administered
Chemical/Occupational Exposure Absent
PTEN Mutation Analysis Was Not Performed
NF1 Mutation Analysis Was Not Performed
RET Rearrangement Analysis Was Not Performed
No History of Gestational Complication
Intercurrent Illness is Absent at Onset of Chief Complaint
Radiation History Negative
IV Anesthesia was not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Tumor Progression Absent After Initial Treatment
First Degree Family History of Primary Brain Tumor Negative
First Degree Family History Cancer Negative
Use of Smokeless Tobacco at Time of Diagnosis Negative

---
https://sides.uness.fr/corpus/Neurologie:H%C3%A9morragie_m%C3%A9ning%C3%A9e
2021
France
educational course
subarachnoid hemorrhage
Hemorrhage
neurology
meningeal hemorrhage
Neurology

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.